A casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr-/-.Leiden mice

BACKGROUND: Obesity frequently associates with the development of non-alcoholic fatty liver disease (NAFLD) and atherosclerosis. Chronic inflammation in white adipose tissue (WAT) seems to be an important driver of these manifestations. OBJECTIVE: This study investigated a combination of an extensiv...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Schoemaker, Marieke H., Kleemann, Robert, Morrison, Martine C., Verheij, Joanne, Salic, Kanita, van Tol, Eric A. F., Kooistra, Teake, Wielinga, Peter Y.
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5498059/
https://ncbi.nlm.nih.gov/pubmed/28678821
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0180648
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars